Neoadjuvant therapy for pancreatic cancer: an intention-to-treat analysis.

Kenjiro OkadaYoshiaki MurakamiKenichiro UemuraNaru KondoNaoya NakagawaShingo SeoHiroyuki OtsukaShinya Takahashi

Published in: Langenbeck's archives of surgery (2020)

A normal CA19-9 level after NAT was an independent predictor of better survival in patients with BRPC. A longer NAT duration might contribute to improved prognosis of patients with elevated CA19-9 levels.

Keyphrases

rectal cancer
lymph node
protein kinase
squamous cell carcinoma
free survival